Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax
Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax: The announcement comes a day after Novovax Inc said that its Covid-19 vaccine Covovax was 89.3% effective…